Modulating PCSK9 and the LDL Receptor: Tipping the Balance of Power

Post on 23-Feb-2016

83 views 0 download

Preview:

Click to see full reader

Tags:

ldlc levelsdosing
ldl receptor
impact of ldl
pcsk9 antibody
modulating pcsk9
cme posttest
cme credit link
observational study

description

Modulating PCSK9 and the LDL Receptor: Tipping the Balance of Power. PRIMO: Observational Study in 7924 Patients. Genetics: PCSK9. PCSK9 Monoclonal Antibody vs Placebo on LDL-C Levels. Dosing and Administration. LAPLACE-TIMI 57: AMG 145 Q2W Dose Response -- Change in LDL-C From Baseline. - PowerPoint PPT Presentation

Modulating PCSK9 and the LDL Receptor: Tipping the Balance of Power

Documents

Transcript of Modulating PCSK9 and the LDL Receptor: Tipping the Balance of Power

PCSK9 Inhibitors - Impact on the Management of LDL ... · LDL Apheresis Currently, there are more than 400 patients in North America receiving LDL apheresis therapy at more than 40

IR Conference Call on PCSK9 - Biotech Due Diligence...Decreasing CV Risk 8 LDL-C Guidelines Have Evolved to More Rigorous Goals These guidelines have identified people with documented

Lipid lowering with PCSK9 inhibitors · 2015-01-30 · Phase III trials of PCSK9 inhibitors are providing evidence on the benefit of additional LDL -C lowering in high-risk patients

PCSK9 Dominant Negative Mutant Results in Increased LDL ... · CEA, Gif sur Yvette, France; APHP, Hoˆpital Saint-Antoine, Biochimie B, Laboratoire de Re´fe´rence pour le Diagnostic

An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top ...An Anti-PCSK9 Antibody Reduces LDL-Cholesterol On Top ... ... 2012, 8

PCSK9 Inhibitors

Familial Hypercholesterolaemia - PCSK9 Forum · Familial Hypercholesterolaemia ... Unilever, Danone , Aegerion ... DNA-based evidence of an LDL-r, apoB-100, or a PCSK9 mutation.

Are PCSK9 Inhibitors the Next Breakthrough in the ... · lipoprotein cholesterol LDL-R = low-density lipoprotein receptor MoAb = monoclonal antibody PCSK9 = proprotein convertase

PCSK9 Inhibitors PP

Kits PCSK9 ELISA Kit & PCSK9-LDLR in vitro Binding Assay ...€¦ · Human PCSK9 ELISA Kit (#CY-8079) Mouse/Rat PCSK9 ELISA Kit (#CY-8078) -Used for the quantitative measurement of

New Horizons in Dyslipidemia Management in Primary … PCSK9 Activity Inhibits Intracellular Degradation of LDL-R Qian YW, et al. J Lipid Res. 2007;48:1488-1498; Horton JD, et al.

Pcsk9 inhibitory

Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: … Lp(a) EAS_FINAL.pdf · Lp(a) and Risk of MI ... history of stroke, PAD, HTN, DM, current smoking, baseline LDL-C •

New Kids on the Block: The Promise of PCSK9 …...Proprotein convertase subtilisin—kexin type 9 (PCSK9) inhibitors are new agents with robust LDL-C lowering, reported between 50-70%

The Value of PCSK9 Inhibitors: A Matter of Perspective€¦ · Autosomal dominant inheritance pattern 2. Most mutations occur in the LDL-receptor gene—on chromosome 19 3. Mutations

Next generation LDL-C management with ALN-PCSsc, an ... · Next generation LDL-C management with ALN-PCSsc, an investigational PCSK9 synthesis ... efficacy and safety of its ... an

PowerPoint Presentation€¦ · Angina pectoris Mutations in LDL receptor, apolipoprotein B or PCSK9 . 200 E 150 100 Homozygous FH Heterozygous FH Female sex Smoking Hypertension

The Chronicles of Berberineassets.a4m.com/assets/webcasts/webcast_pdfs/2013-11-18...2013/11/18 · THE CHRONICLES of BERBERINE C. S. Lewis and R. H. Poling PCSK9, AMPK, and the LDL

Genetic Variants of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Implications for Low-Density Lipoprotein Cholesterol (LDL-C) © 2014 Amgen Inc.

Paul Ehrlich and PCSK9 inhibition: A Magic Bullet for CVD … · 2020-03-10 · e PCSK9 46L rs11591147 ALLHAT-LLT SEARCH Pharmacologically Lower LDL-C A to Z Genetically Lower LDL-C